Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non–nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group
Titel:
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non–nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group
Auteur:
Fountzilas, G. Papakostas, P. Dafni, U. Makatsoris, T. Karina, M. Kalogera-Fountzila, A. Maniadakis, N. Aravantinos, G. Syrigos, K. Bamias, A. Christodoulou, C. Economopoulos, T. Kalofonos, H.P. Nikolaou, A. Angouridakis, N. Stathopoulos, G. Bafaloukos, D. Pavlidis, N. Daniilidis, J.